UncategorizedWhy Citius Pharmaceuticals (CTXR) Stock Is Down 15% Sumain Faisal1 year ago01 mins Citius Pharmaceuticals shares are trading lower by 15% during Wednesday’s session. The company announced a $3 million registered direct offering. read more Post navigation Previous: Oil Price Drop To Cut Exxon Mobil’s Q4 Upstream Earnings By Up To $0.9 Billion: DetailsNext: Novo Nordisk Seeks to Strengthen Obesity Pipeline With Two Back-To-Back Biobuck Deals Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
Miami, Dubai Lead Global Real Estate Bubble Risk Surge As Prices Soar Despite Cooling Markets, UBS Warns Sumain Faisal4 months ago 0
Apple Risks Falling Behind In AI Arms Race, Says Wedbush’s Dan Ives: ‘Biggest Strategic Mistake’ Was Not Buying Netflix Sumain Faisal4 months ago 0